American Association for Cancer Research

Poster Session C

Poster Session C
Monday, February 8
6:30 p.m.-8:00 p.m.

In alphabetical order, not board assignment order

  • A novel method for detection of colorectal cancer using washing fluids obtained by colonoscopy. Seiko Kamimae1, Eiichiro Yamamoto1, Hiro-o Yamano2, Hiromu Suzuki1, Masanori Nojima1, Tamotsu Sugai3, Kohzoh Imai1, Minoru Toyota1. 1Sapporo Medical University, Sapporo, Japan, 2Akita Red Cross Hospital, Akita, Japan, 3Iwate Medical University, Morioka, Japan.
  • A novel phosphoprotein, Ossa/C9orf10 protect cancer cells from oxidative stress-induced apoptosis. Ryuichi Sakai1, Masamitsu Tanaka2. 1National Cancer Center Research Institute, Tokyo, Japan, 2Akita University School of Medicine, Akita, Japan.
  • Acidic stress facilitates tyrosine phosphorylation of HLJ1 to associate with actin cytoskeleton in lung cancer cells. Ching-Hsien Chen1, Sheng-Yi Lin1, Hsuan-Yu Chen2, Chi-Chung Wang3, Jeremy J.W. Chen4. 1National Chung Hsing University, Taichung, Taiwan, 2Institute of Statistical Science, Academia Sinica, Taipei, Taiwan, 3Graduate Institute of Basic Medicine, Fu Jen Catholic University, Taipei, Taiwan, 4Institutes of Biomedical Sciences and Molecular Biology, National Chung Hsing University, Taichung, Taiwan.
  • Akt facilitates the nuclear translocation of IKKα. Wei-Chien Huang. Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan.
  • Alterations in CpG methylation during progression of normal bone marrow plasma cells to multiple myeloma. Bodour Salhia1, Angela Baker1, Daniel Auclair2, Gregory Ahmann3, Jonathan K. Keats3, Bunmi Mfuko4, Joan Levy2, Leif Bergsagel3, Rafael Fonseca3, John Carpten1. 1Translational Genomics Research Institute, Phoenix, AZ, 2Multiple Myeloma Research Foundation, Norwalk, CT, 3Mayo Clinic, Scottsdale, AZ, 4Multiple Myeloma Research Consortium, Norwalk, CT.
  • Association of HOXA11 hypermethylation with non-small cell lung cancer. Jung-Ah Hwang1, Kyun Heo1, Bo Bin Lee2, Joobae Park2, Yeon-Su Lee1, Duk-Hwan Kim2. 1National Cancer Center, Goyang-Si, Gyeonggi-Do, Republic of Korea, 2Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Balance of two PRC1 subunits correlates the progression of breast cancer. Masamoto Kannno1, Takuhiro Ikeda2, Morihito Okada2. 1Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan, 2 RIRBM, Hiroshima University, Hiroshima, Japan.
  • CHFR, a potential tumor suppressor, downregulates interleukin-8 via inhibition of NF-κB. Kashima Lisa1, Toyota Minoru2, Mita Hiroaki1, Suzuki Hiromu3, Idogawa Masashi1, Ogi Kazuhiro1, Sasaki Yasushi1. 1Molecular Biology, Cancer Research Institute, 2Department of Biochemistry, 31st Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan.
  • Circulating miR-92a levels in non-Hodgkin’s lymphoma: A novel biomarker for monitoring lymphoma patients. Tomohiro Umezu1, Kazuma Ohyashiki2, Sei-ichiro Yoshizawa2, Hisashi Kawashima3, Masami Tanaka4, Masahiko Kuroda4, Junko H. Ohyashiki1. 1Intractable Disease Research Center, 2First Department of Internal Medicine (Hematology Division), Departments of 3Pediatrics and 4Pathology, Tokyo Medical University, Tokyo, Japan.
  • Comprehensive profiling of DNA methylation in gastric cancer reveals three subgroups with distinct CpG island methylator phenotype (CIMP). Aparna Vaithilingam1, Marie Loh1, Natalia Liem2, Mengchu Wu1, Pei Woon Ang3, Wei Peng Yong2, Barry Iacopetta3, Richie Soong1 and the Singapore Gastric Cancer Consortium.1Cancer Science Institute of Singapore, National University of Singapore, Singapore, 2National University Hospital, Singapore, 3School of Surgery, The University of Western Australia, Perth, Australia.
  • Comprehensive profiling of genomic DNA methylation in prostate cancer cells using MiGS. Byron H. Lee, Ae-jin Choi, Angela H. Ting. The Cleveland Clinic, Cleveland, Ohio.
  • Development of lung tumors in Cadm1 gene-deficient mice. Masayoshi Nagata1, Mika Sakurai-Yageta1, Taketo Kawai1, Takeshi Ito1, Akihiko Ito1, Midori Yoshida2, Yoshinori Murakami1. 1Division of Molecular Pathology. Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2Division of Pathology, National Institute of Health Sciences, Tokyo, Japan.
  • Downregulation of miR-183 is a shared property of breast cancer stem cells and normal stem cells. Yohei Shimono. Stanford University, Palo Alto, CA.
  • Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. Ryuji Hamamoto1, Masanori Yoshimatsu1, Shinya Hayami1, Motoko Unoki2, Yusuke Nakamura1. 1Institute of Medical Sciences, University of Tokyo, Tokyo, Japan, 2Laboratory for Biomarker Development, RIKEN, Tokyo, Japan.
  • Dysregulation of WHSC1, a histone lysine methyltransferase, involved in human carcinogenesis. Masanori Yoshimatsu1, Shinya Hayami1, Motoko Unoki2, Yusuke Nakamura1, Ryuji Hamamoto1. 1Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2Laboratory for Biomarker Development, RIKEN, Tokyo, Japan.
  • Epigenetic modifications during hapatocellular carcinoma promotion in WW45 haplo-insufficiency mouse model. Ji-Yun Song1, Joo-Hyeon Lee2, Dae-Sik Lim2, Jae Hoon Chung1. 1Laboratory of Mammalian Epigenetics, Korea Advanced Institute of Science and Technology, Daejeon, Korea, 2National Research Laboratory, Laboratory of Molecular Genetics, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
  • Epigenetic regulation of developmental genes in follicular lymphoma and chronic lymphocytic leukemia. Lynda B. Bennett1, Jennifer L. Schnabel1, Jean M. Kelchen1, Kristen H. Taylor1, Gerald L. Arthur1, Christos N. Papageorgio1, Huidong Shi2, Charles W. Caldwell1. 1University of Missouri Columbia, Columbia, MO, 2Medical College of Georgia Cancer Center, Augusta, GA.
  • Epigenomics in cancer biology: The role of the dietary nutrient indole-3-carbinol (I3C). Beverly D. Lyn-Cook, Athena Starlard-Davenport, Cornelius Davis, Beverly Word, George Hammons. FDA/NCTR, Jefferson, AR.
  • ERK pathway regulates the expression of histone modifier protein in cancer cells. Satoshi Fujii, Atsushi Ochiai. Pathology Division, Research Center for Innovative Oncology, National Cancer Center at Kashiwa, Kashiwa, Chiba, Japan.
  • Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Ken-ichi Kozaki1, Issei Imoto2, Seiki Mogi3, Ken Omura3, Johji Inazawa2. 1Hard Tissue Genome Research Center, 2Medical Research Institute, and 3Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
  • Frequent silencing of protocadherin 17, a candidate tumor suppressor for esophageal squamous cell carcinoma. Issei Imoto1, Shigeo Haruki1, Ken-ichi Kozaki1, Takeshi Matsui1, Hiroshi Kawachi1, Shuhei Komatsu1, Tomoki Muramatsu1, Yutaka Shimada2, Tatsuyuki Kawano1, Johji Inazawa1. 1Tokyo Medical and Dental University, Tokyo, Japan, 2Toyama University, Toyama, Japan.
  • Functional screening of tumor-suppressive microRNAs silenced by DNA hypermethylation in endometrial cancer. Tsuruta Tomohiko1, Kozaki Ken-ichi1, Hirasawa Akira2, Banno Kouji2, Susumu Nobuyuki2, Imoto Issei1, Aoki Daisuke2, Inazawa Johji1. 1Medical Research Institute, Tokyo, Japan, 2School of Medicine, Keio University, Tokyo, Japan.
  • Functional screening using a microRNA virus library and microarrays: A new high-throughput assay to identify tumor-suppressive microRNAs. Masashi Izumiya, Naoto Tsuchiya, Koji Okamoto, Hitoshi Nakagama. National Cancer Center Research Institute, Tokyo, Japan.
  • Gene expression-based analysis identifies the unfolded protein response as a target for selective cancer cell killing. Sakae Saito1, Kazuo Shin-ya2, Akihiro Tomida1. 1Cancer Chemother. Ctr., JFCR, Tokyo, Japan, 2Biological Information Research Center, AIST, Tokyo, Japan.
  • Genome-wide analysis of epigenetically silenced genes using next-generation sequencer. Minoru Toyota1, Hiromu Suzuki1, Hiro-o Yamano2, Eiichiro Yamamoto1, Seiko Kamimae1, Hirofumi Akashi1, Reo Maruyama1, Yasuhisa Shinomura1, Kohzoh Imai1. 1Sapporo Medical University, Sapporo, Japan, 2Akita Red Cross Hospital, Akita, Japan.
  • Genome-wide survey of CpG methylation across the spectrum of B-cell lymphomas using methylated CpG island amplification and microarray. Kristen Taylor1, Gerald Arthur1, Lynda Bennett1, Rita Shaknovich2, Ari Melnick2, Jose Ignacio Martin-Subero3, Ole Ammerpohl4, Julia Richter4, Reiner Siebert4, Charles Caldwell1. 1Ellis Fischel Cancer Center, University of Missouri, Columbia, MO, 2Weill Cornell Medical College, New York, NY, 3The Bellvitge Institute for Biomedical Research, Barcelona, Spain, 4Institute of Human Genetics, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Yang Zeng-Quan. Karmanos Cancer Institute, Detroit, MI.
  • Identification of a subgroup with good prognosis of small-cell lung cancer by miRNA expression profiling. Takehiko Oba, Yuichi Ishikawa. The JFCR Cancer Institute, Tokyo, Japan.
  • Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Bernard Kwabi-Addo1, Songping Wang1, Norman H. Lee2, Marcos R. Estecio3, Jaroslav Jelinek3, Woonbok Chung3, Jean-Pierre Issa3, Michael M. Ittmann4. 1Howard University, Washington, DC, 2George Washington University, Washington, DC, 3UT M. D. Anderson Cancer Center, Houston, TX, 4Baylor College of Medicine, Houston, TX.
  • Identification of epigenetically silenced genes by the novel methyl-CpG-targeted transcriptional activation method in human pancreatic cancer. Hideyuki Shimizu, Yuko Sato, Akira Horii, Shinichi Fukushige. Tohoku University School of Medicine, Sendai, Japan.
  • Identification of microRNA epigenetically silenced in bladder cancer. Takashi Shimizu, Hiromu Suzuki, Hiroshi Kitamura, Eiichiro Yamamoto, Kohzoh Imai, Taiji Tsukamoto, Minoru Toyota. Sapporo Medical University, Sapporo, Japan.
  • Identification of nuclear coregulator ANCCA as a new prognostic marker for breast cancer. Ekaterina V. Kalashnikova1, Alexey S. Revenko1, Abigael Gemo1, June X. Zou2, Robert D. Cardiff3, Alexander D. Borowsky3, Hongwu Chen1. 1University of California Davis, Cancer Center/Basic Sciences, Sacramento, CA, 2University of California Davis, School of Medicine, Sacramento, CA, 3Medical Pathology, University of California Davis, School of Medicine, Sacramento, CA.
  • Induction of aberrant DNA methylation by an exogenous factor, Helicobacter pylori infection, and a critical role of inflammation. Toshikazu Ushijima1, Niwa Tohru1, Tatematsu Masae2. 1National Cancer Center Research Institute, Tokyo, Japan, 2Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas. Inoue Jun1, Akiko Misawa2, Yukichi Tanaka3, Shizuko Ichinose4, Hajime Hosoi2, Tohru Sugimoto5, Issei Imoto1, Johji Inazawa1. 1Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan, 2Graduate School of Medical Science, Kyoto Pref. University of Medicine, Kyoto, Japan, 3Kanagawa Children's Medical Center, Yokohama, Japan, 4Instrumental Analysis Research Center, Tokyo Medical and Dental University, Tokyo, Japan, 5Saiseikai Shiga Hospital, Rittou, Japan.
  • Maintenance of systemic IL-6 level was pivotal for concomitant amelioration of tumor susceptibility and metabolic disorders of Snark-deficient mice. Katsuya Tsuchihara, Rumi Fujioka, Hiroyasu Esumi. National Cancer Center Hospital East, Kashiwa, Japan.
  • Methylation of tumor suppressor genes in ovarian cancer. Nejat Dalay1, Filiz Ozdemir2, Zubeyde Yalniz1, Nur Buyru2. 1I.U. Oncology Institute, Istanbul, Turkey, 2Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Methylation status of the LOT1 gene in breast cancer. Nur Buyru, Turgut Ulutin, Seda Ekizoglu. Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Microdialysis and proteomics for protein identification and drug delivery in tumor microenvironment. Baogang Jonathan Xu, Wenwei Yan, Bojana Jovanovic, Qi Angel An, Aubie Shaw, Anna Chytil, Andrew Link, Reid Thompson, Harold Moses. Vanderbilt University, Nashville, TN.
  • MicroRNA expression signatures in hypopharyngeal squamous cell carcinoma (HSCC): miR-489 inhibits cell proliferation by targeting PTPN11. Naoko Kikkawa1, Toyoyuki Hanazawa1, Homare Suzuki1, Takeshi Chiyomaru2, Hideki Enokida2, Masayuki Nakagawa2, Yoshitaka Okamoto1, Naohiko Seki3. Departments of 1Head and Neck Surgery and 3Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan, 2Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Mint3 enhances the activity of hypoxia inducible factor-1 in macrophages by suppressing the activity of factor inhibiting HIF-1. Takeharu Sakamoto, Motoharu Seiki. Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • miR-133a, miR-133b and miR-145 as tumor-suppressive microRNAs by targeting FSCN1 in esophageal squamous cell carcinoma. Naohiko Seki1, Masayuki Kano1, Naoko Kikkawa1, Takeshi Chiyomaru2, Hideki Enokida2, Masayuki Nakagawa2, Hisahiro Matsubara1. 1Chiba University, Chiba, Chiba, Japan, 2Kagoshima University, Kagoshima, Kagoshima, Japan.
  • miRNA 199a* regulates proliferative activity and survival of prostate endothelial cells and breast cancer cells by targeting Caveolin-2. Tatiana Shatseva, Daniel Y. Lee, Zhaoqun Deng, Burton Yang. Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • MiRNA in endothelium and tumor cells in response to angiogenesis inhibitors and radiation. Mechthild Wagner, Ramon Lopez, Ute Wirkner, Peter Huber. DKFZ/University, Heidelberg, Germany.
  • Molecular mechanisms of a disease susceptibility variant of SIRT1: Genotoxic stress-induced, CTCF-dependent activation of SIRT1 gene expression. Xiaoyuan Song1, Miook Cho2, Jeehae Han2, Helen Hazuda2, Ravindranath Duggirala2, John Blangero2, Michael Geoff Rosenfeld1, Yousin Suh2. 1University of California San Diego, La Jolla, CA, 2Albert Einstein College of Medicine, New York, NY.
  • NNK-induced long noncoding transcript 5 (NiT5) is a 2.5 kb antisense, polyadenylated, novel long NCT that is nuclear located, transcribed by RNAP III, and is highly expressed in various cancers. Jessica Monique Silva, David I. Smith. Mayo Clinic Foundation, Rochester, MN.
  • Novel noncoding RNA in 8q24 associated with prostate cancer susceptibility and androgen receptor signaling. Su-youn Chung1, Hidewaki Nakagawa2, Yataro Daigo1, Takahisa Kawaguchi3, Takashi Morizono3, Atsushi Takahashi4, Susumu Saito5, Naoya Hosono5, Tatsuhiko Tsunoda3, Naoyuki Kamatani4, Michiaki Kubo5, Nakamura Yusuke1. 1University of Tokyo, Tokyo, Japan, 2Biomarkers 3Medical Informatics, 4Statistical Analysis, and 5Genotyping Labs, RIKEN, Tokyo, Japan.
  • Organ specific resident cells determine organotropism in metastasis. Takeshi Tomita, Yoshiro Maru. Tokyo Women’s Medical University, Tokyo, Japan.
  • Overexpression of HOXB9 in breast cancer mediates induction of EMT, tumor angiogenesis, and lung metastasis. Tetsu Hayashida1, Fumiyuki Takahashi1, Naokazu Chiba1, Elena Brachtel1, Hiromitsu Jinno2, Yuko Kitagawa2, Shyamala Maheswaran1. 1Massachusetts General Hospital, Charlestown, MA, 2Keio University, Tokyo, Japan.
  • Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Hyun-Soo Cho1, Shinya Hayami1, Masanori Yoshimatsu1, Motoko Unoki2, Yusuke Nakamura1, Ryuji Hamamoto1. 1Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2Laboratory for Biomarker Development, RIKEN, Tokyo, Japan.
  • Overexpression of the JmjC histone demethylase JARID1B contributes to human carcinogenesis through the E2F/RB pathway. Shinya Hayami1, Masanori Yoshimatsu1, Motoko Unoki2, Yusuke Nakamura1, Ryuji Hamamoto1. 1Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2Laboratory for Biomarker Development, RIKEN, Tokyo, Japan.
  • Pathologic cell types of sporadic gastric cancer have different methylation profiles in gastric carcinogenesis. Hyun-Soo Kim, Misuk Yang. Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.
  • Possibility of human microRNA precursor gene (RGM249) on 10p15.3 as tumor-regulating factor. Norimasa Miura. Tottori University, Yonago, Japan.
  • RANKL induced by the tumor microenvironment facilitates epithelial mesenchymal transition and tumor progression. Tamaki Yamada1, Masumi Tsuda1, Hideaki Kawaguchi1, Yasunori Totsuka2, Masanobu Shindoh2, Yusuke Ohba1. 1Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2Hokkaido University Graduate School of Dentistry and Medicine, Sapporo, Japan.
  • Regulation of protein citrullination through p53/PADI4 network in DNA damage response. Chizu Tanikawa, Yusuke Nakamura, Koichi Matsuda. Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
  • Restoration of the methylation status of hypermethylated gene promoters by microRNA-29 in breast cancer: A novel epigenetic therapeutic approach. Athena Starlard-Davenport, Volodymyr P. Tryndyak, Svitlana I. Shpleva, Frederick A. Beland, Igor Pogribny. FDA, National Center for Toxicological Research, Jefferson, AR.
  • Reverse signaling of an EGFR ligand, amphiregulin, suppresses breast cancer cell proliferation and induces cell migration. Hisae Tanaka1, Miki Hieda1, Yu Nishioka1, Shigeki Higashiyama2, Nariaki Matsuura1. 1Osaka University, Suita, Osaka, Japan, 2Ehime Eniversity, Toon, Ehime, Japan.
  • Role of a microRNA/Tp53 feedback circuitry in the pathogenesis and prognosis of chronic lymphocytic leukemia. Muller Fabbri1, Arianna Bottoni1, Riccardo Spizzo2, Milena S. Nicoloso2, Simona Rossi2, Masayoshi Shimizu2, Amelia Cimmino3, Sylwia E. Wojcik1, George A. Calin2, Carlo M. Croce1. 1The Ohio State University, Columbus, OH, 2UT M. D. Anderson Cancer Center, Houston, TX, 3Institute of Genetics and Biophysics A. Buzzati Traverso (IGB), National Research Council, Naples, Italy.
  • Spontaneous tumorigenesis in mice overexpressing Mdm4. Shunbin Xiong1, Vinod Pant1, Carolyn Van Pelt1, Young-Ah Suh1, Yasmine Valentin-Vega2, Guillermina Lozano1. 1UT M. D. Anderson Cancer Center, Houston, TX, 2St. Jude Children’s Research Hospital, Memphis, TN.
  • Testicular germ cell tumors: Could aberrant promoter methylation differentiate seminomas from nonseminomas? Mariana Brait, Leonel Maldonado, Shahnaz Begum, Myriam Loyo, Danielle Wehle, Fabio F. Tavora, Cynthia Lebron, Jeanne Kowalski, Zhe Zhang, George J. Netto, David Sidransky, Mohammad O. Hoque. Johns Hopkins University School of Medicine, Baltimore, MD.
  • The CD44 3’-untranslated region inhibits breast cancer tumorigenesis. Zina S. Jeyapalan1,2, Burton B. Yang1,2. 1Sunnybrook Health Sciences Center, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada.
  • The hypomethylation of H19/Igf2 ICR in Parp-1 knockout mouse ES cells. Hiroaki Fujimori-Sakuma, Hideki Ogino, Takashi Sugimura, Mitsuko Masutani. National Cancer Research Institute, Tokyo, Japan.
  • The origin of colorectal cancer with CpG island methylator phenotype. Eiichiro Yamamoto1, Hiromu Suzuki1, Seiko kamimae1, Hiroo Yamano2, Tamotsu Sugai3, Kohzoh Imai1, Yasuhisa Shinomura1, Minoru Toyota1. 1Sapporo Medical University, Sapporo City, Japan, 2Akita Red Cross Hospital, Akita City, Japan, 3Iwate Medical University, Morioka City, Japan.
  • Transgenic study of Helicobacter pylori CagA oncoprotein in mice. Naomi Ohnishi1, Motohiro Miura1, Shinya Tanaka2, Kohei Yanagiya3, Masanori Hatakeyama3. 1Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan, 2Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Two modes of glioblastoma invasion as visualized by two-photon excitation microscopy. Eishu Hirata, Hiroko Yukinaga, Yuji Kamioka, Yoshiki Arakawa, Susumu Miyamoto, Michiyuki Matsuda. Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Visualizing spatiotemporal dynamics of cell-cycle progression of cancer cells in bone marrow. Aki Hanyu1, Yasumichi Inoue1, Tamiko Minamisawa1, Kiyotaka Shiba1, Asako Sakaue-Sawano2, Atsushi Miyawaki2, Takeshi Imamura1. 1The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan, 2Brain Science Institute, RIKEN, Wako, Japan.
Poster Session A Poster Session B Poster Session C Poster Session D